title: Editorial commentary: getting smart in how we pay for HCV drugs: KAOS vs CONTROL.
authors.affiliation: Center for AIDS Research, University of Alabama at Birmingham.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Saag
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D008297:Male
chemical_list: D000998:Antiviral Agents
keywords: HCV; cost; cost-effectiveness; pharmacy benefit managers; therapy